Literature DB >> 17685868

Looking for novel ways to treat the hallmarks of Alzheimer's disease.

Alistair J Stewart1, Anthony Fox, Bruce H Morimoto, Illana Gozes.   

Abstract

Alzheimer's disease (AD) represents an increasing public health issue as demographic changes and generally improved medical care result in a larger aged population. Although significant advances have been made in the diagnosis and treatment of AD, the unmet medical need remains and few treatment options are available. This review focuses on emerging therapies that aim to treat the underlying causes of the disease rather than the symptoms. Such disease-modifying treatments, focused on the two main hallmarks of the disease (plaques and tangles), include new and old targets which have significant potential in the field and are on the cusp of providing new treatment paradigms within the coming years.

Entities:  

Mesh:

Year:  2007        PMID: 17685868     DOI: 10.1517/13543784.16.8.1183

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  7 in total

Review 1.  Chaperone-like antibodies in neurodegenerative tauopathies: implication for immunotherapy.

Authors:  Eva Kontsekova; Natalia Ivanovova; Martina Handzusova; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-02-13       Impact factor: 5.046

Review 2.  Therapeutic strategies for Alzheimer's disease.

Authors:  Donna M Barten; Charles F Albright
Journal:  Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.590

3.  Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Authors:  Rafael Fernandez-Montesinos; Manuel Torres; David Baglietto-Vargas; Antonia Gutierrez; Illana Gozes; Javier Vitorica; David Pozo
Journal:  J Mol Neurosci       Date:  2009-10-21       Impact factor: 3.444

Review 4.  Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

Authors:  Michael Voronkov; Steven P Braithwaite; Jeffry B Stock
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

5.  Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.

Authors:  Illana Gozes
Journal:  EPMA J       Date:  2010-06-12       Impact factor: 6.543

Review 6.  Peptides for therapy and diagnosis of Alzheimer's disease.

Authors:  Susanne Aileen Funke; Dieter Willbold
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Still debating a cause and diagnostic criteria for Alzheimer's disease.

Authors:  Bogdan O Popescu
Journal:  J Cell Mol Med       Date:  2007-11-20       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.